Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin for Acute Oral Mucositis in Nasopharyngeal Carcinoma Patients Undergoing CCRT
NCT03387774Phase 3Completed
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2018
- Primary completion
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of ulinastatin in oral mucositis (OM), sponsored by Sun Yat-sen University. Started Jan 2018; status: completed.
02
Drugs
ulinastatin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT03387774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03387774.